Stanford University
Showing 18,141-18,160 of 36,178 Results
-
Xing Liang
Basic Life Res Scientist
Current Research and Scholarly InterestsMechanism of MT polarity establishment during PVD neuron dendrite outgrowing in C. elegans.
-
Charles Liao
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsEducational Curriculum: Working with Professional Interpreters
-
Joseph Liao, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Joseph Liao, M.D., is a double board-certified pain management specialist and anesthesiologist at the Stanford University School of Medicine, where he brings a wealth of expertise to the Department of Anesthesiology, Perioperative and Pain Medicine.
His clinical interests span a wide range of pain conditions with an emphasis on back pain, neck pain, joint pain, nerve pain, cancer-related pain, chronic post-surgical pain, and chronic post-traumatic pain. He specializes in neuromodulation, such as spinal cord stimulation, peripheral nerve stimulation, restorative neuromodulation, and dorsal root ganglion stimulation. Dr. Liao’s expertise extends to minimally invasive surgical spine interventions, using techniques like radiofrequency ablation, basivertebral nerve ablation, percutaneous decompression, sacroiliac joint fusion, and steroid injections. He is skilled in using ultrasonography and fluoroscopy to address spine, degenerative joint, and musculoskeletal diseases, as well as neurolysis and ablation for cancer-related pain.
In his research, Dr. Liao focuses on innovative therapies through neuromodulation and minimally invasive spine interventions, with his work published in prestigious peer-reviewed journals such as Anesthesiology and Pain Medicine. He serves as an ad hoc reviewer for multiple pain and anesthesiology journals. He is actively engaged in presenting and teaching at national and international conferences.
Dr. Liao is an avid patient and physician advocate. He takes pride in facilitating safe care and enjoys teaching other physicians how to safely deliver anesthetics and pain care and limit injuries in various forums. He adheres to the philosophy of applying the right treatment for the right patient at the right time. His goal is to utilize minimally invasive interventions to enhance functionality, elevate quality of life, and alleviate pain.
He serves on leadership boards and is affiliated with numerous esteemed medical associations such as the American Society of Interventional Pain Physicians, American Society of Pain and Neuroscience, North American Neuromodulation Society, International Association for the Study of Pain, American Academy of Pain Medicine, Pacific Spine and Pain Society, California Society of Interventional Pain Physicians, American Society of Anesthesiologists, American Association for the Surgery of Trauma, Society of Critical Care Medicine, and World Academy of Pain Medicine United. -
Joseph C. Liao
Kathryn Simmons Stamey Professor
Current Research and Scholarly InterestsThe overarching theme of my scholarship is to develop precision diagnostics in imaging and biomarkers to guide the delivery of precision therapy for urological diseases including bladder cancer, urinary tract infections, and kidney stone disease.
-
Ronglih Liao
Douglass M. and Nola Leishman Professor of Cardiovascular Disease
BioDr. Liao is a Professor of Medicine and co-Director of Stanford Cardiac Amyloid Center. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease. We have described the underlying pathophysiologic basis for amyloid cardiomyopathy and found that the circulating amyloidogenic light chain proteins that characterize this disease directly result in a specific cardiotoxic response. Consequently, our research work has redefined AL cardiomyopathy and has raised new treatment approaches. More recently, her research efforts have expanded to include transthyretin (ATTR) cardiac amyloidosis.
In line with her goal of revealing novel therapeutic strategies for patients with cardiovascular disease, our efforts have also focused on characterizing and harnessing endogenous cardiac regenerative mechanisms. Her laboratory initially demonstrated the therapeutic potential of exogenous primitive muscle cells delivered to the injured heart. This work was among the earliest milestones in the field and served as the basis for an international trial of cell-based therapy. Subsequently, Liao lab identified and characterized a population of cardiac progenitor cells and its relationship and dynamic activity following cardiac injury in the adult heart. Her laboratory aims to reveal the molecular mechanisms regulating the endogenous regenerative capacity of the heart and to harness such repair mechanisms for the treatment of cardiovascular disease. Dr. Liao has lectured extensively on both amyloid cardiomyopathy and stem cell biology, and have maintained a history of independent NIH funding in these areas for more than two decades.
Over the course of her academic career, she has taken the greatest pride in mentoring the next generation of scientists. Dr. Liao has had the privilege to supervise several dozen students, postdoctoral fellows, and junior faculty, many of whom have gone on to independent academic careers at the highest institutions. Her contribution to the advancement of scientific knowledge also includes lecturing at various university and academic institutions as well as at scores of conferences and symposia locally, nationally, and internationally.
